4//SEC Filing
Conatus Pharmaceuticals Inc 4
Accession 0001209191-13-038808
CIK 0001383701operating
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 7:09 PM ET
Size
7.7 KB
Accession
0001209191-13-038808
Insider Transaction Report
Form 4
Cashion Charles
SVP, Finance, CFO and Sec.
Transactions
- Conversion
Common Stock
2013-07-30+43,072→ 149,738 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2013-07-30−355,352→ 0 total(indirect: See footnote)→ Common Stock (43,072 underlying)
Footnotes (2)
- [F1]The outstanding shares of Preferred Stock of the Issuer automatically converted into the shares of Common Stock of the Issuer at the closing of the Issuer's initial public offering at a conversion ratio of 1 share of Common Stock for every 8.25 shares of Preferred Stock, rounded down to the nearest whole number, for no additional consideration.
- [F2]Held in a trust of which Mr. Cashion is a trustee.
Documents
Issuer
Conatus Pharmaceuticals Inc
CIK 0001383701
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001383701
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 7:09 PM ET
- Size
- 7.7 KB